Human leukocyte antigen phenotype imposes complex constraints on the antigen‐specific cytotoxic T lymphocyte repertoire
暂无分享,去创建一个
James McCluskey | J. McCluskey | S. L. Silins | J. Burrows | S. Burrows | S. Elliott | M. Rischmueller | Scott R. Burrows | Sharon L. Silins | Simone M. Cross | Chen Au Peh | Maureen Rischmueller | Jacqueline M. Burrows | Suzanne L. Elliott | S. Cross | Chen Au Peh
[1] W. O'Fallon,et al. Mechanisms underlying the formation of the T cell receptor repertoire in rheumatoid arthritis. , 1995, Immunity.
[2] H. Pircher,et al. Lower receptor avidity required for thymic clonal deletion than for effector T-cell function , 1991, Nature.
[3] G. Schönrich,et al. T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor. , 1992, International immunology.
[4] J. Bell,et al. T‐Cell Receptor Usage of Major Histocompatibility Complex Class I Restricted Peptide‐Specific T‐Lymphocytes , 1995, Annals of the New York Academy of Sciences.
[5] U. Utz,et al. Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis , 1993, Nature.
[6] G. J. V. Nossal,et al. Negative selection of lymphocytes , 1994, Cell.
[7] C. Janeway,et al. Ligand thresholds at different stages of T cell development. , 1990, International immunology.
[8] A. Lanzavecchia,et al. Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.
[9] E. Timms,et al. Tolerance of self induced in thymus organ culture , 1992, European journal of immunology.
[10] C. Bordignon,et al. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. , 1994, Tissue antigens.
[11] S. Hedrick,et al. In vivo and in vitro clonal deletion of double-positive thymocytes , 1992, The Journal of experimental medicine.
[12] L. Sherman,et al. The molecular basis of allorecognition. , 1993, Annual review of immunology.
[13] S. Tonegawa,et al. Evidence for a differential avidity model of T cell selection in the thymus , 1994, Cell.
[14] S. Burrows,et al. Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants , 1988, Nature.
[15] J. Burrows,et al. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.
[16] A. Fauci,et al. New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.
[17] D. Mark,et al. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. , 1984, Science.
[18] M. Bevan,et al. Positive selection of thymocytes. , 1995, Annual review of immunology.
[19] R. Houghten. General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[20] J. Todd,et al. A molecular basis for MHC class II--associated autoimmunity. , 1988, Science.
[21] D J Moss,et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus , 1994, The Journal of experimental medicine.
[22] M. Doyle,et al. Biological activity of recombinant human interleukin-2 produced in Escherichia coli. , 1984, Science.
[23] S. L. Silins,et al. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.
[24] W. Henle,et al. Immunofluorescence in Cells Derived from Burkitt's Lymphoma , 1966, Journal of bacteriology.
[25] G. Hitman,et al. New HLA DNA polymorphisms associated with autoimmune diseases , 1986, Nature.
[26] H. Grey,et al. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[27] A. Begovich,et al. Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis , 1993, Nature.